InvestSMART

MedAdvisor Limited (ASX: MDR) - Announcements

Current share price for MDR : $0.022 0.002 (10%)+

ASX company news and announcements for MedAdvisor Limited (MDR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MedAdvisor Limited (MDR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MedAdvisor Limited (MDR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MedAdvisor Limited (MDR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 3Y - Exercise of Read performance rights 19 Oct 2020 4:11PM $0.410 $0.022 fallen by 94.63%
- Appendix 2A - Exercise of employee options & rights 19 Oct 2020 4:08PM $0.410 $0.022 fallen by 94.63%
- Appendix 3G - Grant of employee incentive options 19 Oct 2020 4:04PM $0.410 $0.022 fallen by 94.63%
- MDR September 2020 Quarterly Report & Appendix 4C 13 Oct 2020 10:48AM $0.405 $0.022 fallen by 94.57%
- Appendix 2A Exercise of employee incentive options 25 Sep 2020 12:04PM $0.445 $0.022 fallen by 95.06%
- Appendix 3Y Lapsing of Read Employee Incentive Options 24 Sep 2020 8:18AM $0.445 $0.022 fallen by 95.06%
- MedAdvisor launches ePrescribing across Australia 17 Sep 2020 9:59AM $0.425 $0.022 fallen by 94.82%
- MedAdvisor Appendix 4G Updated 1 Sep 2020 7:17PM $0.465 $0.022 fallen by 95.27%
- MedAdvisor Corporate Governance Statement 2020 1 Sep 2020 7:16PM $0.465 $0.022 fallen by 95.27%
- MedAdvisor FY20 Results Presentation 27 Aug 2020 8:33AM $0.500 $0.022 fallen by 95.60%
- MedAdvisor 2020 Appendix 4G 27 Aug 2020 8:33AM $0.500 $0.022 fallen by 95.60%
- MedAdvisor Releases FY20 Results 27 Aug 2020 8:30AM $0.500 $0.022 fallen by 95.60%
- MedAdvisor 2020 Annual Report & Appendix 4E 27 Aug 2020 8:27AM $0.500 $0.022 fallen by 95.60%
- MedAdvisor Appoints a Company Secretary and General Counsel 25 Aug 2020 2:35PM $0.455 $0.022 fallen by 95.16%
- MedAdvisor FY20 Results Call 25 Aug 2020 12:46PM $0.460 $0.022 fallen by 95.22%
- Response to ASX Appendix 3Y Query 30 Jul 2020 3:28PM $0.485 $0.022 fallen by 95.46%
- MedAdvisor Appendix 3Y - Vesting of Read Rights 27 Jul 2020 5:36PM $0.500 $0.022 fallen by 95.60%
- MedAdvisor Appendix 3Y - Vesting of Read Rights 27 Jul 2020 5:35PM $0.500 $0.022 fallen by 95.60%
- MedAdvisor Appendix 3G - Issue of Employee Incentive Options 27 Jul 2020 5:19PM $0.500 $0.022 fallen by 95.60%
- MedAdvisor June 2020 Appendix 4C Cash Flow Statement 27 Jul 2020 10:36AM $0.465 $0.022 fallen by 95.27%
- MedAdvisor June 2020 Quarterly Activities Report 27 Jul 2020 10:34AM $0.465 $0.022 fallen by 95.27%
- Vesting of CEO Employment Rights 10 Jul 2020 4:24PM $0.550 $0.022 fallen by 96%
- MedAdvisor strikes strategic alliance with NASDAQ-listed HMS 1 Jul 2020 9:52AM $0.500 $0.022 fallen by 95.60%
- MDR Appendix 2A and Cleansing Notice 29 Jun 2020 4:05PM $0.480 $0.022 fallen by 95.42%
- Change in substantial holding 29 May 2020 4:57PM $0.610 $0.022 fallen by 96.39%

476 - 500 of 761 results

Page 20 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.